Search results
Results from the WOW.Com Content Network
The triptan drug class includes 1st generation sumatriptan (which has poor bioavailability), and second generation zolmitriptan. [2] Due to their safety, efficacy and selectivity, triptans are considered first line agents for abortion of migraines. [2]
Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches. This drug class was first commercially introduced in the 1990s. This drug class was first commercially introduced in the 1990s.
Excessive use may result in medication overuse headaches. [3] Use is not recommended during pregnancy and breastfeeding is not recommended within 24 hours after taking a dose. [4] Rizatriptan is in the triptan class and is believed to work by activating the 5-HT 1 receptor. [3] Rizatriptan was patented in 1991 and came into medical use in 1998.
Medication overuse headache is a recognized ICHD (International Classification of Headache Disorders) classification. [4] Over the years different sets of diagnostic criteria have been proposed and revised by the major experts of headache disorders. The term MOH first appeared in the ICHD 2nd edition in 2004.
The frequent use of medication may result in medication overuse headache (MOH), in which the headaches become more severe and more frequent. [6] This may occur with triptans, ergotamines, and analgesics, especially opioids or narcotic analgesics. [6] [7] Combination of opioids with other analgesics is thought to nearly double the risk of MOH. [8]
Like all triptans, almotriptan has a high and specific affinity for serotonin 5-HT 1B/1D receptors. Binding of the drug to the receptor leads to vasoconstriction of the cranial (brain) blood vessels and thus affects the redistribution of blood flow. Almotriptan significantly increases cerebral blood flow and reduces blood flow through ...
Zolmitriptan is a triptan and a substituted tryptamine. [ 3 ] [ 4 ] It is specifically the derivative of N , N -dimethyltryptamine (DMT) in which the hydrogen atom at position 5 of the indole ring has been substituted with a [(4 S )-2-oxo-1,3-oxazolidin-4-yl]methyl group .
Frovatriptan, sold under the brand name Frova, is a triptan drug developed by Vernalis for the treatment of migraine headaches [1] and for short term prevention of menstrual migraine. [2] The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe.